The Scientist

» vaccine and cell & molecular biology

Most Recent

image: Some Human Cancers Exhibit Low-grade Inflammation

Some Human Cancers Exhibit Low-grade Inflammation

By | October 1, 2016

NSAIDs reduce this "parainflammation," hinting at how they help lower cancer risk.

0 Comments

image: Gene Editing: From Roots to Riches

Gene Editing: From Roots to Riches

By | October 1, 2016

Advances in genetic manipulation have simplified the once daunting task of rewriting a gene.

2 Comments

image: Scientists Catch Translation in the Act

Scientists Catch Translation in the Act

By | October 1, 2016

Newly developed techniques from four different groups rely on the same basic steps to track translation in live cells.

0 Comments

image: Stem Cells Made Waves in Biology and Medicine

Stem Cells Made Waves in Biology and Medicine

By | October 1, 2016

Since their introduction to the lab, pluripotent stem cells have gone from research tool to therapeutic, but the journey has been rocky.

0 Comments

image: Thirty Years of Progress

Thirty Years of Progress

By | October 1, 2016

Since The Scientist published its first issue in October 1986, life-science research has transformed from a manual and often tedious task to a high-tech, largely automated process of unprecedented efficiency.

1 Comment

image: Americas Declared Measles-Free

Americas Declared Measles-Free

By | September 30, 2016

Health officials announce that measles is no longer endemic to any region in the Americas, thanks to widespread vaccination.

0 Comments

image: Congress Approves $1.1 Billion for Zika

Congress Approves $1.1 Billion for Zika

By | September 30, 2016

The money will go toward vaccine development and assisting communities at risk.

0 Comments

image: Circadian-Controlled Thirst

Circadian-Controlled Thirst

By | September 28, 2016

Scientists determine how the brain’s central clock regulates drinking prior to sleep in rodents.

1 Comment

image: Broadly Neutralizing Antibodies in HIV Patients

Broadly Neutralizing Antibodies in HIV Patients

By | September 28, 2016

Researchers identify aspects of the patient, the virus, and the infection itself that influence whether a person with HIV will produce broadly neutralizing antibodies.

0 Comments

image: Facebook CEO’s Donation a Boon to Basic Science

Facebook CEO’s Donation a Boon to Basic Science

By | September 25, 2016

But can $3 billion dollars meet the lofty goals of the Chan Zuckerberg Initiative?

1 Comment

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. What Budget Cuts Might Mean for US Science
    News Analysis What Budget Cuts Might Mean for US Science

    A look at the historical effects of downsized research funding suggests that the Trump administration’s proposed budget could hit early-career scientists the hardest.  

  3. Opinion: On “The Impact Factor Fallacy”
  4. Unstructured Proteins Help Tardigrades Survive Desiccation
Business Birmingham